Research Partnership appoints new CEO
January 9, 2023 |
Research Partnership has appointed Gareth Phillips to take over as CEO
Research Partnership has appointed Gareth Phillips to take over as CEO, effective 9th January 2023. The two co-founding Directors, Mary Assimakopoulos and Mark Jeffery, are taking a step back from the operational running of the business, although they will remain on the Senior Management Team in an advisory capacity.
Research Partnership was acquired by Inizio last year and sits within the Advisory business unit. Inizio is a strategic partner for health and life sciences that unites a full suite of advisory, medical, marketing, communications, and patient and stakeholder engagement services.
Gareth was previously UK Managing Director and Head of EMEA for Ipsos, one of the world’s leading market research companies. He brings with him a wealth of global experience, having spent 25 years in healthcare market research working with IMS Health (now IQVIA) and Synovate Healthcare before it was acquired by Ipsos. At Synovate, he held roles based in the US, UK and Asia, and was the company’s Managing Director of Asia Pacific at the time of integration into Ipsos. Whilst at Ipsos, he spearheaded a transformation of the healthcare business in Europe, leading them to achieve consistent high growth over the past decade, and growing the team in London to more than 250 people.
Commenting on his appointment, Gareth said, “I am delighted and honoured to be taking on the role as CEO. I have long admired Research Partnership as a leader in the global healthcare market research space and look forward to building on the incredible success that Mark and Mary have achieved in the last 25 years.”
Previous co-Founding Director Mark Jeffery adds, “Gareth is a highly regarded figure in healthcare market research, and with him, we know that the company is in safe hands. We are confident that he will continue the strong growth that the company has enjoyed since its inception in 1997. We wish him every success.”
Gareth will report to Colin Stanley, President of Inizio Advisory.
To find out more about Research Partnership, visit www.researchpartnership.com
To find out more about Inizio and Inizio Advisory, please visit: www.inizio.health
This content was provided by Inizio
Company Details
Latest Content from Inizio
Smarter science, sharper strategy: Expert insights from ASCO® 2026
As the oncology landscape continues to evolve, life sciences organizations face a growing challenge: how do you communicate increasingly complex science in a way that creates meaningful engagement?
Intelligent Commercialization™ across the pharma lifecycle
Pharma teams are under growing pressure to navigate launch complexity, identify risks earlier, and engage HCPs more effectively.
Four steps to a smarter congress strategy: A practical guidebook
This guidebook explores how Intelligent Congress helps pharma teams create more coordinated, measurable, and impactful congress strategies.
Infographic: Are data blind spots putting your launch at risk?
Commercial pharma launches depend on confident, evidence-led decisions. Yet many launch teams are still working with fragmented data spread across multiple systems, making it difficult to understand market readiness, prioritize…
Key takeaways from ASCO® 2026
Following ASCO® 2026, Inizio’s experts have shared their perspectives across three thought leadership articles, each exploring a different aspect of what this year’s congress revealed for pharmaceutical organisations. Together, they…
Webcast | Smarter science, sharper strategy: Expert perspectives from ASCO® 2026
Key insights from ASCO® 2026, including oncology trends, scientific highlights, and strategies for smarter congress engagement.
From activity to impact: 5 takeaways from MAPS Americas 2026
Across sessions, panels, and conversations on the ground in Denver, there was a noticeable shift in both mindset and momentum. Many of the themes discussed in previous years are now…
Inizio launches Intelligent Congress: Turning medical event investment into measurable impact
Inizio, the global commercialization partner to the health and life sciences industry, today announced the launch of Intelligent Congress – a connected, end-to-end solution designed to help pharma organizations maximize…
Inizio Unveils Next-Generation Hub Services at Asembia 2026, Setting a New Standard in Patient Access
Integrated capabilities combining advanced analytics, pharmacy, and specialized talent to improve access, affordability, and adherence
5 takeaways from Reuters’ Pharma USA 2026 – and what they mean for you
Pharma USA is North America’s largest cross-functional pharma event and Inizio was there to offer insights on patient engagement, accelerated product launches, and Intelligent Commercialization™. Now we’re back in the…